Table 2 Prevalence and magnitude of antibody response to merozoite antigens by age group in Lampung
Season | Antigen | Age group (N) | 1-4 | 5-9 | 10-15 | 16-25 | 26-40 | >40 |
|---|---|---|---|---|---|---|---|---|
Low | PfMSP1-19 | Prevalence | 0 (62) | 1.3(96) | 15.5(84) | 43.1(58) | 61.8(123) | 61.7(94) |
Mean OD | 0.080 | 0.081 | 0.11 | 0.182 | 0.263 | 0.329 | ||
High | PfMSP1-19 | Prevalence | 6.9(72) | 8.4(71) | 22.1(68) | 46.1(65) | 63.4(134) | 91.2(80) |
Mean OD | 0.083 | 0.096 | 0.125 | 0.164 | 0.247 | 0.460 | ||
Low | PfAMA1 | Prevalence | 3.2(62) | 3.2(96) | 22.6(84) | 43.1(58) | 66.7(123) | 67.0(94) |
Mean OD | 0.091 | 0.078 | 0.111 | 0.161 | 0.272 | 0.324 | ||
High | PfAMA1 | Prevalence | 6.9(72) | 14.1(71) | 20.6(68) | 47.7(65) | 58.2(134) | 78.7(80) |
Mean OD | 0.072 | 0.100 | 0.111 | 0.168 | 0.247 | 0.429 | ||
Low | Combined | Prevalence | 5.0(62) | 16.7(96) | 38.1(84) | 58.6(58) | 78.5(123) | 80.5(94) |
High | Prevalence | 16.8(72) | 25.3(71) | 44.1(68) | 60.0(65) | 66.4(134) | 95.0(80) |